HK1042847A1 - 骨代謝異常症治療劑 - Google Patents

骨代謝異常症治療劑

Info

Publication number
HK1042847A1
HK1042847A1 HK02104289.0A HK02104289A HK1042847A1 HK 1042847 A1 HK1042847 A1 HK 1042847A1 HK 02104289 A HK02104289 A HK 02104289A HK 1042847 A1 HK1042847 A1 HK 1042847A1
Authority
HK
Hong Kong
Prior art keywords
bone
treating agent
pathobolism
pathobolism treating
agent
Prior art date
Application number
HK02104289.0A
Other languages
English (en)
Inventor
望月伸一
藤瀨暢彰
增山千春
津田英資
東尾侃二
Original Assignee
三共株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 三共株式會社 filed Critical 三共株式會社
Publication of HK1042847A1 publication Critical patent/HK1042847A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02104289.0A 1998-10-28 2002-06-05 骨代謝異常症治療劑 HK1042847A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32287498 1998-10-28
PCT/JP1999/005963 WO2000024416A1 (fr) 1998-10-28 1999-10-28 Agents therapeutiques pour deformations osseuses

Publications (1)

Publication Number Publication Date
HK1042847A1 true HK1042847A1 (zh) 2002-08-30

Family

ID=18148585

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104289.0A HK1042847A1 (zh) 1998-10-28 2002-06-05 骨代謝異常症治療劑

Country Status (21)

Country Link
US (1) US6919312B2 (zh)
EP (1) EP1127578A4 (zh)
JP (1) JP3860415B2 (zh)
KR (1) KR20010082272A (zh)
CN (1) CN1183961C (zh)
AU (1) AU755422B2 (zh)
BR (1) BR9914834A (zh)
CA (1) CA2347107A1 (zh)
CZ (1) CZ20011378A3 (zh)
HK (1) HK1042847A1 (zh)
HU (1) HUP0104126A3 (zh)
IL (1) IL142557A0 (zh)
MX (1) MXPA01004225A (zh)
NO (1) NO20012106L (zh)
NZ (1) NZ511506A (zh)
PL (1) PL347559A1 (zh)
RU (1) RU2223782C2 (zh)
TR (1) TR200101146T2 (zh)
TW (1) TW529954B (zh)
WO (1) WO2000024416A1 (zh)
ZA (1) ZA200103296B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
EP1127578A4 (en) 1998-10-28 2004-12-15 Sankyo Co MEDICINE FOR BONE METABOLIC DEVIATIONS
US6593310B1 (en) * 2000-11-21 2003-07-15 Arthropharm Pty. Ltd. Treatment of osteoporosis
ES2337716T3 (es) 2001-04-03 2010-04-28 Societe Des Produits Nestle S.A. Osteoprotegerina en la leche.
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
EP1482978A1 (en) * 2002-03-01 2004-12-08 Sankyo Company, Limited Pharmaceutical composition comprising osteoclastogenesis inhibitory factor
AU2003242265A1 (en) * 2002-06-07 2003-12-22 Sankyo Company, Limited Combined effects of therapeutic or preventive agent composition for bone breakage
BRPI0611535B1 (pt) 2005-05-05 2021-11-30 Sensient Flavors Inc Método para processar células de levedura para produzir beta-glucanos e mananas
JPWO2008041774A1 (ja) * 2006-10-02 2010-02-04 独立行政法人物質・材料研究機構 骨伝導能を有する徐放性製剤
US20090028954A1 (en) * 2006-12-22 2009-01-29 Mathys Ag Bettlach Precursor for the preparation of a pasty bone replacement material by admixture of a liquid
EP2509607B1 (en) * 2009-12-09 2017-09-06 Agency For Science, Technology And Research Glycosaminoglycan mixtures
CN113088487B (zh) * 2020-04-30 2022-12-06 威海见生生物技术有限公司 一种间充质干细胞成脂转化抑制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2604135B2 (ja) * 1986-02-28 1997-04-30 ライオン株式会社 口腔骨疾患治療剤
IL91438A (en) * 1989-08-25 1995-03-30 Bukh Meditec Preparation for treating dental disease
TW318142B (zh) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US20030207827A1 (en) * 1995-12-22 2003-11-06 William J. Boyle Osteoprotegerin
US6369027B1 (en) 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
JPH1057071A (ja) 1996-08-19 1998-03-03 Snow Brand Milk Prod Co Ltd 新規ｄｎａ及びそれを用いた蛋白質の製造方法
RU2238949C2 (ru) 1997-04-15 2004-10-27 Санкио Компани Лимитед Белок, специфически связывающийся с ингибирующим остеокластогенез фактором (ocif) (варианты), днк его кодирующая (варианты), днк в качестве зонда (варианты), способ получения белка (варианты), способ скрининга вещества (варианты), антитело (варианты), способ получения поликлонального антитела, гибридома (варианты), способ получения моноклонального антитела, способ измерения ocif-связывающего белка, фармацевтическая композиция (варианты) и лекарственное средство (варианты)
US6656508B2 (en) * 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
ATE328281T1 (de) * 1997-09-24 2006-06-15 Sankyo Co Methode zur diagnose von abnormalem knochenstoffwechsel
WO1999065916A1 (en) 1998-06-15 1999-12-23 Takeda Chemical Industries, Ltd. Thienodipyridine derivatives, production and use thereof
EP1127578A4 (en) 1998-10-28 2004-12-15 Sankyo Co MEDICINE FOR BONE METABOLIC DEVIATIONS
WO2001003719A2 (en) 1999-07-09 2001-01-18 Amgen Inc. Combination therapy for conditions leading to bone loss
CA2349406C (en) * 1999-09-03 2011-01-11 Amgen Inc. Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
MXPA02006027A (es) 1999-12-16 2002-12-05 Amgen Inc Moleculas tipo osteoprotegerina/receptor del factor de necrosis de tumor y usos de las mismas.
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
EP1482978A1 (en) * 2002-03-01 2004-12-08 Sankyo Company, Limited Pharmaceutical composition comprising osteoclastogenesis inhibitory factor

Also Published As

Publication number Publication date
NO20012106D0 (no) 2001-04-27
KR20010082272A (ko) 2001-08-29
TW529954B (en) 2003-05-01
IL142557A0 (en) 2002-03-10
HUP0104126A3 (en) 2004-07-28
HUP0104126A2 (hu) 2002-03-28
AU6487799A (en) 2000-05-15
CZ20011378A3 (cs) 2001-10-17
BR9914834A (pt) 2001-08-14
JP3860415B2 (ja) 2006-12-20
RU2223782C2 (ru) 2004-02-20
CA2347107A1 (en) 2000-05-04
EP1127578A1 (en) 2001-08-29
TR200101146T2 (tr) 2001-09-21
CN1183961C (zh) 2005-01-12
US6919312B2 (en) 2005-07-19
ZA200103296B (en) 2001-10-25
EP1127578A4 (en) 2004-12-15
PL347559A1 (en) 2002-04-08
NZ511506A (en) 2004-02-27
MXPA01004225A (es) 2002-06-04
AU755422B2 (en) 2002-12-12
US20010031725A1 (en) 2001-10-18
CN1325310A (zh) 2001-12-05
NO20012106L (no) 2001-06-21
WO2000024416A1 (fr) 2000-05-04

Similar Documents

Publication Publication Date Title
AU140490S (en) Action trooper
GB9821218D0 (en) Treatment for fabrics
GB9800942D0 (en) Well treatment
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
HUP0102808A3 (en) Ectoparasiticide agents
HK1042847A1 (zh) 骨代謝異常症治療劑
GB9816556D0 (en) Therapy
EP1048300A4 (en) DEINTEGRATION AGENT
EP1008352A4 (en) Cerebrospinal PROTECTOR
ZA987483B (en) Contrast agent
GB9912851D0 (en) Treating cells
EP1043364A4 (en) TONER
GB9805519D0 (en) Processes
GB9815497D0 (en) Treatment
GB9818524D0 (en) Inorgasmia treatment
EP0935965A4 (en) SUBSTANCE AGAINST PYLORI
GB9903035D0 (en) Treating cancer
PL324932A1 (en) Mould-killing agent
GB9827088D0 (en) Silylating agent
GB9828550D0 (en) Treatment
AU1167P (en) Treat xTriticosecale
GB2334579B (en) Treating cancer
GB2335437B (en) Treating hide
GB9812914D0 (en) Treatment
GB9929620D0 (en) Off-gas treatment